METAVIA INC. Retained Earnings
METAVIA INC. (MTVA) had Retained Earnings of -$157.97 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$157.97M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$152.65M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$148.83M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$146.90M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$157.97M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$152.65M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$148.83M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$146.90M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$143.52M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$139.53M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$135.86M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$130.68M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$125.03M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$114.98M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$108.27M 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$102.95M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$99.13M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$98.40M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$95.80M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$91.12M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$88.01M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$84.70M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$81.83M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$77.25M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$73.79M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$69.87M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$66.54M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$47.03M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | -$43.98M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | -$41.60M 10-Q · filed 2020-05-20 | |
| 2019-12-31 | -$36.87M 10-K · filed 2021-04-15 | |
| 2019-09-30 | -$94.26M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$90.83M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$87.91M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$15.55M 10-K · filed 2020-03-30 | -$84.11M 10-K · filed 2019-03-18 |
| 2018-09-30 | -$80.45M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$74.38M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$67.70M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$60.47M 10-K · filed 2019-03-18 | |
| 2017-09-30 | -$53.73M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$45.06M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$34.55M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$27.06M 10-K · filed 2018-03-20 | |
| 2016-09-30 | -$19.84M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | -$15.97M 10-Q · filed 2016-09-14 | |
| 2015-12-31 | -$12.39M 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |